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SUMMARY
The two forms o f interleukin-1, IL -la  and IL -1 [3 respectively, and tumour 
necrosis factor (TNF) are polypeptides sharing different biological activities 
which are often associated with host defence mechanisms. Because o f the well- 
recognized benefits o f  breast feeding for newborns, colostrum from 9 healthy 
lactating women was analysed for the presence o f these 3 cytokines. Specific 
radioim m unoassay revealed that colostrum contains a significant amount o f  
IL-1 [3 (m ean±SE M  values o f  1 ,130±259 pg/m l). The concentrations o f IL-la  
and TNF were negligible.
Colostral leukocytes are able to produce IL-1 since high activity was found 
after stimulation with Staphylococcus epiderm idis. In addition, these cells 
produced IL-1 spontaneously in v itro , in contrast to resting maternal blood  
m onocytes. As IL-1 increases resistance to infection, the presence o f this 
cytokine represent a beneficial aspect o f breast feeding.
K ey-w ord s: C olostrum , Interleukin-1, Leukocyte; Breast feeding, 
Resistance to infection.
INTRODUCTION
Interleukin-1 (IL-1) represents a family o f polypeptides synthesized by the 
host mainly in response to a variety o f stimuli. Two types o f IL-1 (a and [3)
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recognize the same receptor on lymphocytes and act as extracellular signals 
usually amplifying the development o f antigen-specific immunity (Dinarello, 
1988; Lowenthal and M acDonald, 1986; Durum et al., 1985). IL-1 also pos­
sesses many non-im m unological properties including effects on endocrine, 
nervous, vascular and mesenchymal cells (Dinarello, 1986). Both forms o f  
IL-1 share many activities with another cytokine, cachectin or tumour necro­
sis factor (TNF) (Dinarello, 1986).
IL-1 activity has been demonstrated in human body fluids including plas­
ma (Cannon and Dinarello, 1985), urine (Kimball et al., 1984) and joint ef­
fusions (Fontana et al., 1982; W ood et al., 1983), often in association with 
the existence o f a pathological state. Recently, the presence o f TNF has also 
been described in serum o f patients with severe infectious purpura (Girardin 
et al. , 1988) and P lasm odium  fa lc iparum  malaria (Kern et al., 1989). It re­
mains unclear whether one or both IL-1 forms and/or TNF participate in 
normal physiological function in the absence o f infection or injury.
Breast milk provides optimal feeding for the newborn with well-established 
nutritional advantages (Committee on Nutrition, 1980; ESPG A N  Com m it­
tee on Nutrition, 1982). In fact, human milk has many unique properties 
clearly beneficial for the neonate since it contains biochemical com ponents 
(Lonnerdal, 1985) and immunological factors (Chandra, 1978; Pittard, 1979; 
Welsh and May, 1979; Victora et al., 1987) which satisfy their nutritional 
requirements and augment their defence mechanisms against infectious 
diseases.
We studied the presence o f both IL-1 ’s and TNF in colostrum o f healthy 
women during early maternal lactation using specific radioimmunoassays to 
measure the different cytokines. Colostral leukocytes (CL) were also studied 
as the possible cellular source o f IL-1 and were compared, on a cellular ba­
sis, with blood m ononuclear cells (BM NC) from the same mothers for IL-1 
production.
M A T E R IA L S  A N D  M ET H O D S
Study design.
Nine lactating Chilean mothers (age±SD 27 ±5.7 years) who delivered normal 
full-term infants (38-40 weeks) were included in the study. A ll women in good health,
BMNC
CAP
CL
IL
blood mononuclear cell, 
colostral aqueous phase, 
colostral leukocyte, 
interleukin.
LPS
MEM
R1A
TNF
lipopolysaccharide. 
minimal essential medium, 
radioimmunoassay, 
tumour necrosis factor.
INTERLEU KIN-lfi IN  HUM AN COLOSTRUM 507
that is, without known organic disease, signs of infection or breast inflammation. 
The study was explained to volunteers and informed consent was obtained.
Isolation of CL, colostral aqueous phase (CAP) and BMNC.
Milk and blood samples were obtained on the 3rd to 4th postpartum day. Colos­
trum (10 ml/mother) was collected by manual expression into sterile plastic tubes 
and immediately placed at 4°C. CL were removed by centrifugation and were over 
90 % viable as determined by trypan blue exclusion. Mean cellular concentration 
was approximately l.Ox 105/ml of whole colostrum. Morphological analysis showed 
that the typical distribution of CL in colostrum was 60 % macrophages, 30 °7o poly­
morphonuclear leukocytes and 10 °7o lymphocytes. Once CL were separated, CAP 
was obtained by centrifugation at 10,000 g for 10 min at 4°C in order to remove 
particulate material and fat, and was then stored at -  70°C. At the same time peripher­
al blood (10 ml) was obtained.
BMNC were isolated over Ficoll-Hypaque and washed three times in pyrogen- 
free saline. Both CL and BMNC were resuspended in minimal essential medium 
(MEM, Microbiological, Walkerville, MN) which had been passed through an 
ultrafilter in order to remove endotoxins (Dinarello et al., 1987a). Cells were used 
at a final concentration of 2.5 x 105/ml containing 1 % heat-inactivated human AB 
serum.
Immunoreactive assay.
Immunoreactive cytokines including IL-ip (Lisi et al., 1987), IL-la (Lonnemann 
et al., 1988) and TNF-a (van der Meer et al., 1988) were tested in colostrum itself 
by using a specific radioimmunoassay (RIA). There is no cross-reactivity between 
IL-ip RIA and that of IL-la. The TNF assay recognizes TNF-a but neither form 
of IL-1, nor lymphotoxin (TNF-P), interferons, or colony stimulating factors (van 
der Meer et al., 1988). Samples were spiked with known amounts of each cytokine 
and were recovered (95-100 %) as measured in each cytokine RIA.
Production of IL-1 by colostral and blood cells.
Cells (CL and BMNC) were incubated in flat-bottomed microtitre plates (96 wells) 
overnight at 37°C in either MEM or heat-inactivated Staphylococcus epidermidis (bac­
teria/leukocyte ratio 10/1). The plates were then exposed to 3 freeze-thaw cycles and 
supernatants containing both extracellular and cell-associated material were frozen 
at -  70°C until assayed. The supernatants were serially diluted and tested on the sen­
sitive IL-l-responsive murine helper T-cell line D10.G4.1 (Kaye et al., 1984), which 
detects less than 1 pg/ml of IL-1 (Orencole et al., 1987).
Triplicate 100 (jlI supernatants of CL and BMNC with/without stimulants were 
added to equal volumes of D10.G4.1 cell suspensions ( 2 x l 0 5/ml in complete 
RPMI-1640 supplemented with 5 °7o heat-inactivated foetal calf serum; Hyclone 
Laboratory, Logan, UT). The cultures were incubated for 48 h at 37° C in 5 % C 0 2, 
pulsed with 1.0 jxCi of tritiated thymidine (6.7 Ci/mmol;  New England Nuclear, 
Boston, MA), and incubated for an additional 18 h then harvested. Incorporated 
radioactivity was determined by liquid scintillation. The amount of IL-1 was calcu­
lated using half-maximal proliferative responses to recombinant human IL-ip as the 
definition of 1 unit/ml as previously described (Dinarello et al., 1987b). Because the 
number of monocytes differed in CL compared to BMNC cell preparations, the data 
were expressed as IL-1 units/104 monocytes ± SEM.
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RESULTS
We measured the concentra t ions o f  immunoreact ive  I L - 1 (3, IL - la  and  T N F  
in co los t rum . Table  I shows the a m o u n ts  o f  these cytokines in C A P  from
9 healthy m others .  H igh levels o f  IL - ip  were found  with a m ean  value o f  
1,130 p g /m l .  C oncen t ra t ion s  o f  I L - l a  and  T N F  were 10 times lower, that  
is, ab o u t  100 p g /m l  for bo th  cy tokines ;  these values were close to the detec­
tion limit o f  the technique .  We also evaluated  IL - ip  in “ early m a t u r e ”  milk 
(day 7) f rom  a su b g ro u p  o f  lactating m o th e rs ;  a l though  the concen tra t ion  
varied, it was generally abou t  ha l f  tha t  in co los t rum  (da ta  not  shown).
After finding that C A P  from normal mothers contained significant amounts  
o f  IL-1 , we then studied the p roduc t ion  o f  this cytokine by C L  in vitro. There 
was high sp o n tan eo u s  IL-1 activity f rom  uns t im ula ted  C L  from  m others  
(fig. 1); in com par ison ,  uns t im ula ted  m ate rna l  b lood  m onocytes  p roduced  
very low am ounts  o f  IL-1 . In addition, S. epidennidis-sl\m\\\aiQâ CL produced 
considerably  m ore  IL-1 than  s t imula ted  B M N C  from  the same m others .
DISCUSSION
In this repor t ,  we d em o n s t ra te  the presence o f  IL - ip  in h u m a n  co los t rum  
o f  healthy mothers  in the absence o f  infection or injury, clinical events which 
are often associated with the presence o f  this cytokine (Dinarello et a/., 1987b). 
In add i t ion ,  o ther  investigators have also described IL-1 activity in norm al  
am nio t ic  fluid (Brody et al., 1987).
T a b l e  I. — Immunoreactive cytokines in human CAP.
Cytokine (pg/ml)
Mother IL-ip IL-la TNF
1 1,100 100 120
2 1,500 110 80
3 360 240 80
4 1,200 150 110
5 400 110 90
6 380 90 110
7 700 130 90
8 2,500 150 100
9 2,000 170 110
Range 360-2,500 90-240 80-120
Mean ± SEM 1,130 ± 239 139 ± 14 99 ± 5
CAP was tested in duplicate in the respective R IA  for IL-1(3, IL-la and TNF. The detection limit 
was 80 pg/ml for all three cytokines at the 95 %  confidence level.
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Recently, Soder  (1987) observed tha t  h u m a n  milk from healthy Swedish 
m others ,  1-3 m on ths  af te r  the onset o f  lacta t ion,  conta ins  an I L - 1 -like factor  
tha t  is very similar to m acrophage-der ived  IL - la .  However ,  the presence o f  
o ther  I L - 1 -like factors  derived from the active co m ponen ts  o f  milk was not 
excluded.
Using specific RIA techniques, we found  both forms o f  IL-1 in c o lo s t ru m ; 
the concentra t ion  o f  IL-la being extremely low and close to the detection limit 
o f  the assay. F u r th e rm o re ,  IL-1 [3 was also detected in “ early m a tu re  m i lk ”  
(day 7), a l though  the concen tra t ion  was ab o u t  ha lf  that  found  in co los t rum . 
Thus ,  it is possible tha t  the kinetics o f  the  p roduc t ion  o f  IL-la and IL-ip 
vary dur ing  the course o f  lactat ion in a similar m an n e r  to  o ther  im m u n o lo g i ­
cal factors  (G o ld m an  et al., 1982).
Using a T-cell b ioassay,  we could  not  accurately  detect IL-1 in u n f rac t io ­
nated colostrum because o f  the presence o f  inhibiting substances. The presence 
o f  inhibi tors  o f  T-cell p ro l i fera t ion  in h u m a n  milk is not surpris ing because 
inhibi tory  substances are found  in most  h u m a n  body  fluids such as p lasma,  
urine, peritoneal fluid and  joint  effusions (C annon  and Dinarello, 1985; Kim­
ball et al., 1984; F o n ta n a  et al., 1982; W o o d  et al., 1983). In order  to re­
move these inhibitors,  we ch ro m a to g rap h ed  C A P  by gel-fil tration and ,  using 
a bioassay,  we detected IL-1 activity in the 40-50- and  15-20-kD fractions.  
W e were able to conf i rm  tha t  this im m u n o s t im u la to ry  activity in C A P  was 
due to IL-1 by specific neutra l iza t ion  with anti-IL-1 antibodies .
Since there were high levels o f  IL-1(3 in C A P ,  we investigated whether  the 
colostral cells were the source o f  IL-1. We found that S. epidermiclis-stimulated 
C L  p roduced  significant am o u n ts  o f  IL-1 in vitro. On the o ther  hand ,  CL 
“ sp o n tan eo u s ly ”  produced  this cytokine. W hen  IL-1 p roduc t ion  by unstimu-
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Fig. 1. — IL-1 production by CL compared with BMNC.
Bars represent the mean±SEM IL-1 activity of CL and BMNC from 9 healthy mothers who 
delivered normal full-term infants.
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lated CL and  b lood  m onocytes  was com p ared ,  the activity was negligible in 
m aterna l  B M N C , indicating that  culture condi t ions  were not responsible for 
the spon tan eou s  p roduc t ion  o f  IL-1 by CL. This result was achieved by e m ­
ploying ultra-f i l tered media  dur ing  the incubat ion  period,  a step which ex­
cludes endo tox in  co n tam in a t io n  (Dinarello  et al., 1987a).
We have shown tha t  B M N C  o f  over 100 individuals and  the 9 m others  
in the present s tudy do  not p roduce  IL-1 spon taneous ly .  Thus ,  the s p o n ta n e ­
ously p roduced  IL-1 by C L  was p ro b ab ly  due to activation in vivo. These 
findings are consistent with the spontaneous oxidative metabolic activity (Pick­
ering et al., 1980) and  the phagocytosis  and  killing o f  bacter ia  and  fungi 
(R obinson  et al., 1878; B haskaram  and  Reddy,  1981) repor ted  for milk m a c ­
rophages .
Since s taphylococcal  infections are relatively c o m m o n  in children in de­
veloping countr ies ,  we chose to show d a ta  on IL-1 p ro d u c t io n  by C L  using
S. epidermic/is as a s t imulus.  A l though  som e au tho rs  have found  that  cap su ­
lar materia l  f rom  per iodon ta l  pa thogens  a lone may have some IL-1-like ac­
tivity (Harvey et al., 1987), we used heat- inact ivated  S. epidermidis  as it does 
not interfere with the m agn i tude  o f  responses o f  either colostral  m acrophages  
or  b lood  m onocytes .
Recently, Subiza et al. (1988) repor ted  a limited ability o f  h u m a n  breast 
milk macrophages to produce IL-1 in vitro in response to bacterial lipopolysac- 
charide (LPS) from Escherichia coli. It is possible tha t  C L  are m ore  sensible 
to S. epidermidis  than  to LPS a n d / o r  that  the capacity o f  LPS to induce IL-1 
varies depending  on the concen tra t ion  and  the strain source.  For  example,  
b lood  m onocytes  f rom  norm al  adul ts  p roduce  higher a m o u n ts  o f  bo th  im- 
m unoreac t ive  IL-1 [3 and  T N F  in response  to S. epidermidis  c o m p are d  with 
LPS (Endres  et al., 1988). On  the o ther  han d ,  L PS  (1 (ig/ml) f rom  E. coli 
is 3-4 times less potent  than  LPS  (1 [Jig/ml) f rom  Neisseria meningitidis  for 
inducing IL-1 (H aeffner-C ava i l lon  et al., 1989).
IL-1 is of ten  considered as m ed ia to r  o f  an acute  response  to microbia l  in ­
vasion, in f lam m at ion  and  tissue injury.  Its presence in h u m a n  co los t rum ,  an 
env ironm ent  free from pathological  processes, suggests a physiological role. 
A l though  a possible im m u n o reg u la to ry  role o f  milk IL-1 in pro tec t ing  the 
m a m m a ry  gland from bacterial  infections is not  d iscarded,  we suggest that  
preferentially,  the beneficial effect o f  this cytokine is on neonates  since they 
are immunological ly  im m atu re  at bir th .  As IL-1 is relatively acid resistent 
(Dinarello ,  1984) and  the s tom ach  p H  o f  new borns  varies between 2.3-3.6, 
it can be speculated tha t  this molecule survives the transit  and  is abso rbed  
in the gastro in tes t inal  t rac t .  In add i t ion ,  there is evidence tha t  the gas t ro in ­
testinal tract o f  suckling m am m als  possesses the ability to absorb  various p ro ­
teins with substant ia l  preservat ion  o f  their  im m unolog ica l  propert ies  
(Lawrence,  1985). Also, as IL-1 increases na tu ra l  resistance to infection in 
g ranu locy topen ic  mice (van der Meer et al., 1988), and  is identical to 
haemopoiet in-1  (Mochizuki  et al., 1987), t ransfe r  o f  this co los trum -derived  
cytokine to the neona te  may play a role in augm ent ing  host  defence m e c h a n ­
isms and  im proving  resistance to  infection.
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RESUM E
L ’INTERLEUKINE-lp d a n s  l e  c o l o s t r u m  h u m a in
Les deux formes d ’interleukine-1 (IL- la  and IL- lp ) et le “ tumour necrosis fac- 
tor”  (T N F) sont des cytokines possédant des activités diverses, souvent associées aux 
mécanismes de défense de l’hôte. En raison de l’effet bénéfique et bien reconnu de 
l’allaitement maternel, la présence de ces trois cytokines a été analysée dans le colos­
trum de 9 jeunes femmes. A  l’aide de tests radioimmunologiques spécifiques, il a 
été montré que le colostrum contenait des quantités significatives d’IL-ip (moyenne ± 
SEM  = 1130± 259 pg/ml). Les concentrations d’IL- la  et de T N F étaient au contraire 
extrêmement faibles.
Les leukocytes présents dans le colostrum sont capables de produire de F IL - 1 
puisqu’une forte activité IL-1 a été retrouvée après stimulation de ces cellules par 
Staphylococcus epidennidis. Par ailleurs, nous avons observé que ces cellules pro­
duisent spontanément de l’IL-1 in v itro , contrairement aux monocytes provenant des 
personnes examinées. Dans la mesure où l’IL-1 augmente la résistance à l’infection, 
la présence de cette cytokine dans le colostrum peut être considérée comme l’un des 
facteurs bénéfiques de l’allaitement maternel.
M o t s-c l é s : Colostrum, Interleukine-1, Leucocyte; Allaitement, Résistance aux 
infections.
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